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Human Blastocyst Formation and 
Development
Hilma Putri Lubis and Binarwan Halim
Abstract
The preimplantation period of human embryo development is remarkable and 
characterized by successive changes in terms of genetic control, physiology, and 
morphology of the embryo. Human preimplantation embryo development is char-
acterized by the initial phase of embryo development, the phase before the embryo 
implantation process. In normal conditions, after fertilization, the embryo grows 
until the blastocyst stage. The blastocyst grows as the cells divide and the cavity 
expands, where it “hatches” from the zona pellucida to implant into the endome-
trium. Reprogramming and programming are continuous processes in the embryo 
that encompasses fusion of the egg and sperm pronuclei; epigenetic reprogram-
ming and modification, an extensive wave of degradation of maternal transcripts, 
and activation of the nascent human embryonic genome and aneuploidy can occur 
in this stage. The embryo produces cytokines, growth factors, and receptors for 
endometrial signals in the apposition stage.
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1. Introduction
Preimplantation embryo development is characterized by a series of events 
after fertilization including the formation of the maternal and paternal pronuclei, 
followed by the formation of the zygote, which at ±20 hours after insemination 
starts undergoing mitotic divisions every 12–18 hours (cleavage stage), reaching the 
morula (compaction), and the blastocyst grows as the cells divide and the cavity 
expands, until it arrives at the uterus, where it “hatches” from the zona pellucida 
to implant into the endometrium. The main objective of blastocyst culture was to 
increase the success rate of in vitro fertilization (IVF) because of better embryo 
selection. Blastocyst culture has also been used as a tool to select the most viable 
embryos in a cohort with a consequent reduction in the number of embryos trans-
ferred and the corresponding reduction in the incidence of multiple gestations. 
This chapter will review about human blastocyst formation and development and 
discuss about the physiology, morphology, and gene expression of the blastocyst.
2. Physiology of the blastocyst
The transformation of the fertilized oocyte into the blastocyst is not only 
characterized by major morphological events but also by dramatic changes in its 
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physiology, reflected in changes in the relative activity of the metabolic pathways 
which provide not only energy but also the biosynthetic intermediates required to 
support proliferation [1]. The ability of the cleavage stage embryo to react in the 
environment during early cleavage is limited because the human genome embryo is 
still inactive and the system that regulates the balance of the osmotic pressure is not 
fully functional [1, 2].
The tendency of metabolism to produce energy from pronucleate oocytes until 
blastocyst stage can be assessed from mitochondrial forms. In the stage of pronu-
cleate oocytes and cleavage stage, their mitochondrial form is still immature, and 
the production of energy in oocytes is usually low and will be increased tremen-
dously from cleavage stage embryo until blastocyst stage. In the stage of pronucleate 
oocytes, the type of metabolism is oxidative phosphorylation (OXPHOST); then in 
the cleavage stage embryo, the metabolism uses lactate, pyruvate, specific amino 
acids, and fatty acids [1–3].
In the blastocyst stage, the metabolism produces energy that mainly depends on 
the process of glycolysis, with anabolic dominantly seen in the mitochondria [3, 4].
Figure 1. 
Tricarboxylic acid (TCA) cycle or the Krebs cycle. The citric acid cycle begins with one acetyl-CoA molecule 
reacting with one molecule of H2O, releasing a coenzyme-A group, and donating the remaining two carbon 
atoms in the form of an acetyl group to oxaloacetic acid which has molecules with four carbon atoms, to produce 
citric acid with six carbon atoms. The outcome products of the first turn of the cycle are one GTP (or ATP), 
three NADH, one QH2, and two CO2. Because two acetyl-CoA molecules are produced from each glucose 
molecule, two cycles are required per glucose molecule. Therefore, at the end of two cycles, the final products are 
two GTP, six NADH, two QH2, and four CO2.
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Figure 2. 
Glycolysis pathway or Embden-Meyerhof-Parnas (EMP) pathway. (1) In the first stage, glucose will be 
converted to glucose 6-phosphate by the hexokinase enzyme. This stage requires energy from adenosine 
triphosphate (ATP). The ATP that has released the stored energy will change to ADP. (2) Glucose 
6-phosphate will be converted to fructose 6-phosphate which is catalyzed by the enzyme phosphohexose 
isomerase. (3) Fructose 6-phosphate will be converted to fructose 1,6-bisphosphate; this reaction is 
catalyzed by the enzyme phosphofructokinase. In this reaction, energy from ATP is needed. (4) Fructose 
1,6-bisphosphate (6 C atoms) will be broken down into glyceraldehyde 3-phosphate (3 atoms C) and 
dihydroxy acetone phosphate (3 atoms C). The reaction is catalyzed by the enzyme aldolase. (5) One molecule 
of dihydroxy acetone phosphate that is formed will be converted to glyceraldehyde 3-phosphate by the enzyme 
triose phosphate isomerase. The enzyme works back and forth, meaning it can also convert glyceraldehyde 
3-phosphate to dihydroxy acetone phosphate. (6) Glyceraldehyde 3-phosphate will then be converted to 
1,3-bisphosphoglycerate by the enzyme glyceraldehyde 3-phosphate dehydrogenase. In this reaction NADH 
will be formed. (7) 1,3 bisphosphoglycerate will be converted to 3-phosphoglycerate by the phosphoglycerate 
kinase enzyme. These reactions will be released as energy in the form of ATP. (8) 3-phosphoglycerate will 
be converted into 2-phosphoglycerate by the phosphoglycerate mutase enzyme. (9) 2-phosphoglycerate will 
be converted to phosphoenolpyruvate by the enzyme enolase. (10) Phosphoenolpyruvate will be converted to 
pyruvate which is catalyzed by the pyruvate kinase enzyme. In this stage also produced energy in the form 
of ATP.
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In the cleavage stage embryo, pyruvate uptake increases continuously until the 
blastocyst stage. In the blastocyst stage, glucose uptake is higher than pyruvate 
uptake, and O2 consumption will increase in the initial development stage before 
compaction (pre-compaction). In the pre-compaction stage, we can observe low 
biosynthetic activity, low O2 consumption, and ovoid form of mitochondria; the 
main nutrition is pyruvate, with dominant maternal genome where cells divide in 
the similar shape [1–3].
In the post-compaction stage, we can observe high biosynthetic activity, higher 
oxygen consumption, and elongated form of mitochondria; the main nutrition is 
glucose, and with dominant human embryo genome. In this stage, cells will be dif-
ferentiated into trophectoderm (TE) and inner cell mass (ICM) [1–3, 5].
Amino acids in the metabolism of blastocyst can be used as a source of energy, 
and some amino acids such as aspartate through malate aspartate shuttle enter in 
the tricarboxylic acid (TCA) cycle to produce energy. However, glutamine can also 
Figure 3. 
Metabolism of the blastocyst. After compaction, there is an increase in oxygen consumption and utilization of 
glucose as a source of energy (glycolysis). The increase in oxygen consumption reflects the considerable energy 
required for the formation and maintenance of the blastocoel, but the increase in glucose utilization reflects 
an increased demand for biosynthetic process. In TCA cycles, it produces NADH, GTP, QH, and CO2 and 34 
ATP. PEP, phosphoenolpyruvate.
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enter as glutamate in the TCA cycle to produce energy. Amino acid in the blastocyst 
stage also plays a role in the regulation of intracellular pH buffer, as a material 
development process and as antioxidants and chelators [1–3, 5].
After compaction, the embryo exhibits increased of O2 consumption and glucose 
usage capacity as an energy source. This oxygen consumption increase shows that 
the energy is needed for the formation and maintenance of blastocoel [1–3, 5].
Increased metabolism of the blastocyst occurs due to the increased release of 
blastomere to 150–200 cells with the formation and maintenance of blastocoel 
through the activity of Na+/K+ ATPase pump which produces energy. Energy is 
needed for the degradation of the zona pellucida with protease enzyme. Pyruvate 
as a source of energy reserves other than carbohydrates also functions as an antioxi-
dant [1–3, 5].
The human blastocyst uses amino acids as a source of energy in the catabolism 
process and produces ammonium 30 pmol/hour. The most used amino acid is aspar-
tate, besides consuming arginine, serine, methionine, valine, and leucine [1–3, 5].
Metabolism of the blastocyst occurs in two different places: in trophectoderm 
(TE) cells where glucose consumption occurs and half is converted to lactate, 
whereas glycolysis process occurs in inner cell mass (ICM) (Figures 1–3) [1–3, 5].
3. Morphology of the blastocyst
In in vitro fertilization (IVF), the blastocyst culture was important to increase 
the success rate of IVF because of better embryo selection after better genomic 
activation and endometrial receptivity [6]. The blastocyst comprises two cell types: 
the inner cell mass (ICM, from which the fetal tissues develop) and the trophecto-
derm (which will form mostly extraembryonic tissues such as the placenta [1]). This 
morphological differentiation was thought to represent the developmental capabil-
ity of the blastocyst [6, 7].
3.1 Degree of expansion
The fluid accumulation presence between cells at the morulae stage is the 
phase that determines embryonic development. The accumulated fluid will form 
blastocoel gradually which usually occurs on day 4 and/or on the beginning of day 
5 human embryo stage which marks the development of new embryos known as 
the blastocyst stage. An increase in fluid volume and the number of cells in the 
blastocyst causes an enhancement in the size cavity of the blastocyst and its cavity 
with depletion of the zona pellucida (ZP) [6]. The number of cells that comprise a 
blastocyst can vary considerably as shown in one study to range between 24 and 322 
cells, which is often reflected in the blastocyst’s morphology [8].
The stages of blastocyst embryo development are divided into four grades. A 
grade of 1 is given to the embryo with blastocoel cavity less than 50% of the embryo 
volume. A grade of 2 is given to the embryo with blastocoel cavity as much as 50% 
of the embryo volume or even more than that. A grade of 3 was given to the embryo 
that had a blastocoel cavity which had fulfilled that all embryos and zona pellucida 
(ZP) appeared to be thinner than embryo on day 3. A grade of 4 is given to the 
embryo that has successfully hatched from ZP [6, 9].
3.2 ICM morphology
A collection of cells located within the blastocoel in one pole of the blastocyst 
cavity is called ICM. ICM will develop into fetal tissue. ICM consists of tightly 
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packed cells and loosely bound cells that cause the size of the ICM very large and/
or small morphologically [6]. The morphological form of ICM is assessed based on 
how much the cell compaction is until there is no cell clot at all. A grade of 1 is given 
to ICM with a very large and dense form of cell clots. A grade of 2 is given to ICM 
with a slightly diffuse cell form. A grade of 3 is given to ICM with very few cells and 
which does not even form clots. However, the best ICM grade (A) contains tightly 
packed and many cells; the middle ICM grade (B) is composed of loosely grouped 
and several cells, and the worst grade (C) describes an ICM that contains very few 
cells that are loosely bound [6, 9].
3.3 TE morphology
The outer cells of the blastocyst, forming the blastocyst structure itself, are called 
the trophectoderm (TE) cells. TE cells play a role in the formation of fluid accumu-
lation in the blastocoel which can be a key in ICM determination, but in the early 
stages of the blastocyst stage, the role of TE cells is unclear. TE cells will develop into 
extraembryonic tissue such as the placenta. In addition, TE cells are thought to play 
a role in the implantation process which the TE cells have contributed in the phase 
of apposition, adhesion, and invasion of the endometrium which can support the 
implantation of the blastocyst in the uterus. Molecular factors are also produced by 
TE cells that play a role in the embryo implantation process [6–9]. The TE cells have 
traditionally been graded in a similar manner to the ICM, i.e., by their number and 
cohesiveness according to three different grades (A, B, C). According to blastocyst 
grading by Gardner and Schoolcraft, the best TE cell grade (A) contains many cells 
that form a cohesive epithelium; the middle TE category (B) is composed of few cells 
forming a loose epithelium, and the worst category (C) describes a TE that contains 
very few large cells that struggle to form a cohesive epithelium. However, other 
publications have found no relationship between TE grade and viability (Figure 4) 
[6, 8, 9].
Gardner and Schoolcraft in 1999 introduced the blastocyst grading system 
which is adopted by the majority of IVF laboratories in the world. In the blasto-
cyst grading system, they classified the degree of blastocyst into three category, 
Figure 4. 
Blastocyst morphology. (1) inner cell mass (ICM), (2) blastocoel, and (3) trophectoderm.
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i.e., degree of expansion, inner cell mass (ICM) quality, and the trophectoderm 
(TE) cell quality [6, 10].
Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of 
Embryology states that a good embryo on day 5 which is examined at 116 ± 2 hours 
must be in the form of blastocyst [9].
Embryo, according to the Istanbul consensus, is given a grade based on three 
things; the first thing is the embryo development stage, the second is ICM, and 
the third is TE. So that the order of the fifth day embryo assessment is based on 
the stages of development, then based on ICM morphology, and the last is based 
on TE. The following is a presentation of the fifth day embryo according to the 
Istanbul consensus (Figures 5–9; Table 1) [6, 9].
Figure 5. 
Blastocyst (grade 4: A: A) means that the blastocyst has been expanded (grade 4), has a large ICM and 
compact (grade A), and has TE which consists of many cells which are mutually binding (grade A).
Figure 6. 
Blastocyst (grade 4: C: C) means that blastocyst embryo has been expanded (grade 4), has ICM that is 
difficult to see and has very few cells (grade C), and has TE which has very little cell (grade C).
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Figure 8. 
Blastocyst (grade 2: A: A) embryos that have embryo development stage with a grade of 2 are blastocyst 
embryos which still have thick ZP.
Figure 9. 
Blastocyst (grade 5: A: A) means that blastocyst embryo which has come out of its shell (grade 5) has ICM 
whose cells are large and easy to observe (grade A) and has TE consisting of many cells (grade A).
Figure 7. 
Early blastocyst is the fifth day embryo development stage which has a blastocoel less than 50% of the embryo 
volume, and the formation of ICM and TE is not clear.
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4. Gene expression of human preimplantation embryo
The human embryo preimplantation development is characterized by repro-
gramming and programming that encompasses fusion of the egg and sperm pro-
nuclei, epigenetic reprogramming, an extensive wave of degradation of maternal 
transcripts, and activation of the nascent human embryonic genome [11, 12].
There are 1909 genes expressed in only oocytes (maternal genome) and 3122 
genes expressed in only blastocyst (embryonic genome). The main difference in 
observed profile expression between oocytes and embryos is reflected in blasto-
cyst and oocyte specific gene expression analysis. Specific oocyte and blastocyst 
genes are separated in groups by expression levels. There are 270 specific oocyte 
genes and 308 blastocyst-specific genes that show high levels of expression. In 
the panther pathway analysis of high expression genes, the MII oocyte pathway is 
Wnt signaling pathway, where blastocyst-specific genes are expressed according to 
integrin signaling pathway, cytoskeletal regulation. The scarcity of the materials, 
however, both in size (10.1 mm diameter) and in quantity (only a few to tens of 
oocytes from each ovulation), have been almost the molecular analysis of preim-
plantation embryos [11–13].
Some interesting patterns in embryo preimplantation based on transcriptional 
genome-wide analysis include: (1) several genes that experience up- or downregula-
tion during human oocyte maturation from immature germinal vesicle oocyte to 
the oocyte metaphase II stage; (2) partially expressed transcripts of the MII oocytes 
will be partially downregulated or degraded during the development to the 4-cell 
stage; (3) many genes are upregulated after the 4-cell stage, which reflects the main 
wave Embryonic Genome Activation (EGA); (4) genes involved in lineage commit-
ment are regulated in the development of preimplantation; and (5) many expressed 
genes dynamically encode transcription factors, epigenetic modifying factors, and 
chromatin remodeling [12–16].
Expansion 
grade
Blastocyst development and stage status
1 Early blastocyst—Blastocoel cavity less than half the volume of the embryo
2 Blastocyst—Blastocoel cavity more than half the volume of the embryo
3 Full blastocyst—Blastocoel completely filling the embryo
4 Expanded blastocyst—Blastocoel volume is now larger than that of early embryo and zona 
is thinner
5 Hatching out of the shell
6 Hatched out of the shell
ICM grade Inner cell mass quality
A Tightly packed and many cells
B Loosely grouped and several cells
C Very few cells
TE grade Trophectoderm quality
A Many cells forming a cohesive epithelium
B Few cells forming a loose epithelium
C Very few large cells
Table 1. 
The blastocyst grading system. Modified from Gardner and Schoolcraft.
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Human genome activation begins in the 4- and 8-cell stages or even in the 
early 2-cell stage. Data suggest that TE or ICM cell lineage-associated genes 
are expressed in human embryos later than in mice at around early blastocyst 
stage, but it is still unclear. Human embryos can be cultured in vitro for 7–8 days 
post-fertilization. Genes unique in the blastocysts included annexins A2 and A3 
(ANXA2, ANXA3), gap junction protein alpha 1 (GJPA1), guanosine triphos-
phate-binding protein 4 (GTPBP4), and adenosine triphosphatase H.–transport-
ing, lysosomal accessory protein 1 (ATP6AP1). The blastocyst-specific genes were 
associated with oxidative phosphorylation, glycolysis, and sterol metabolism and 
were rich in RNA-binding proteins, methyltransferases, gap junction proteins, 
and intermediate filaments. Oxidative phosphorylation and glycolysis processes 
control ATP generation during pre-compaction and cavitation stages, respectively. 
Highly expressed blastocyst genes were involved in the Rho GTPase, control 
pathway that regulates cytoskeletal changes occurring during cell growth and 
development; the PDGF pathway, which plays a critical role in cellular prolifera-
tion and metabolism, and the integrin signaling pathway are also important in 
actin reorganization [12–19].
Studies on gene expression during the preimplantation period have identified 
transcription factors from housekeeping genes, transcription and growth factor 
genes, sex-determining genes, tissues specifics, novel genes, and genes of unknown 
functions [12, 13].
4.1 Housekeeping gene
Housekeeping gene is a gene that plays a role in regulating basal cell function 
which is important in cell maintenance and also has a specific role in tissues or 
organisms. Therefore, housekeeping gene is estimated to be expressed in all cells of 
organism normally, including tissue, external signal, cell cycle, or cell development 
stage [12, 13, 20].
Beta-actin, keratin-18, ubiquitous cytoskeletal elements, cell adhesion molecules, 
and alpha tubulin have been detected, as well as such housekeeping genes as hypo-
xanthine phosphoribosyl transferase (HPRT), adenosine phosphoribosyl transferase 
(APRT), glucose-6-phosphate dehydrogenase, hexokinase I, and adenosine deami-
nase. Overall, out of the 536 housekeeping genes investigated, 427 were detected in 
the oocyte and 452 in the blastocyst [12, 13, 20].
4.2 Transcription and growth factor genes
Transcription regulators, growth factors, proto-oncogenes cycle gene cells, 
and receptors are several genes that expressed during the preimplantation period, 
including CD44, a cell surface glycoprotein that can play a role in implantation; 
OCT 4 and OCT 6, transcriptional regulators; cyclin B1, a cell cycle gene; colony 
stimulating factor 1 receptor, c-fms; tumor necrosis factor and its receptors; inter-
leukin-1 type I receptor (IL-1R tI); growth factors such as insulin and their recep-
tors; epidermal growth factor receptor (EGF-R), epidermal growth factor (EGF), 
and transformation of growth factor-alpha (TGF-α) [12, 13, 17–19].
4.3 Tissue-specific genes, novel genes, and genes of unknown function
A major histocompatibility complex molecule was detected in preimplantation 
human embryos and implicated tissue-specific genes as globin and interleukin-10 
and also human transposable element, LINE-1, and known expressed sequence tags 
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(ESTs) in the GenBank and dbEST databases. Of the 46 peptide hormone genes 
investigated, 13 were detected in the human blastocysts (SPAG9, TMSB10, OXT, 
POMC, PPY, SCT, LHB, TRH, PRLH, GNRH2, GIP, CCK, and GPHB5) of which 
four, namely, SPAG9, TMSB10, OXT, and POMC, showed high expression levels. 
Thirty-two out of the 162 investigated genes coding for human HRs were detected 
in the human blastocysts, of which NPM1, ATP6AP2, LEPROTL1, and HTR1D 
showed high expression levels [12, 13, 15–17, 21].
Aneuploidy is common in humans and is the leading cause of all human birth 
defects as well as miscarriage; errors can arise in meiosis during generation of the 
oocyte and sperm and in the mitotic divisions of the nascent embryo. A recent 
study used array-based technology to examine the genome-wide copy number of 
distinct loci in the cleavage stage human embryos. This study identified several 
types of chromosomal abnormalities that occurred in human embryos and observed 
that mosaicism for whole chromosomes (aneuploidies) in one or more blastomeres 
occurred in more than 80% of embryos [11, 12, 17, 22].
5. Conclusions
Human preimplantation embryos will become an integral and essential part 
of such endeavors by setting the genetic foundation that determines the course 
of human development. It is characterized by reprogramming and programming 
that encompasses fusion of the egg and sperm pronuclei, epigenetic reprogram-
ming, an extensive wave of degradation of maternal transcripts, and activation 
of the nascent human embryonic genome. The main objective of blastocyst 
culture was to increase the success rate of in vitro fertilization (IVF) because of 
better embryo selection after endometrial synchronicity and/or better genomic 
activation. Metabolism of the blastocyst occurs in two different places: in 
trophectoderm cells where glucose consumption occurs and half is converted to 
lactate, whereas glycolysis occurs in ICM. Morphology of the blastocyst depends 
on the degree of expansion and ICM and TE morphology. This morphological 
differentiation was thought to represent the developmental capability of the 
blastocyst. Gene expression during the preimplantation period has identi-
fied transcription factors from housekeeping genes, transcription and growth 
factor genes, sex-determining genes, tissues specifics, novel genes, and genes 
of unknown functions. Genes unique in human blastocysts included annexins 
A2 and A3 (ANXA2, ANXA3), gap junction protein alpha 1 (GJPA1), guanosine 
triphosphate-binding protein 4 (GTPBP4), and adenosine triphosphatase H.–
transporting, lysosomal accessory protein 1 (ATP6AP1). The blastocyst-specific 
genes were associated with oxidative phosphorylation, glycolysis, and sterol 
metabolism.
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